A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
A new study presented at the 2024 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting reveals a concerning rise in endometriosis prevalence among pregnant women over the past 2 decades.1
Endometriosis, which affects approximately 10% of reproductive-aged women, has been associated with various health complications.1
According to the World Health Organization (WHO), some of these health complications include:2
“Addressing endometriosis will empower those affected by it by supporting their human right to the highest standard of sexual and reproductive health, quality of life and overall well-being,” according to WHO.2
The retrospective cohort study presented at ACOG, using data from the Healthcare Cost and Utilization Project, Nationwide Inpatient Sample (HCUP-NIS) database, provides an in-depth analysis of the condition’s prevalence and its implications during pregnancy.
The study analyzed data from 16,911,497 births without endometriosis and 14,956 births to women diagnosed with the condition between 1999 and 2019.
The findings indicate a significant increase in endometriosis diagnoses among pregnant women, from 34.9 to 160.6 per 100,000 births over the 20-year period.
Women with endometriosis exhibited distinctive demographic traits: they were more likely to be of advanced maternal age, predominantly Caucasian, from higher income brackets, obese, smokers, and covered by private insurance.
Other key findings from the study include:
“The study highlights the evolving prevalence of endometriosis among pregnant women and establishes a strong connection between endometriosis and adverse maternal and newborn outcomes,” the authors wrote.
They concluded, “These findings emphasize the importance of vigilant monitoring to enhance obstetrical and fetal outcomes in pregnant women with endometriosis.”
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More